“Neurotransmitters in the TME: Can Dopamine and Glutamate Be the Next Cancer Targets?” (2026) Journal of Biomolecules, Pathogenesis and Therapeutics, 2(3), pp. 111–112. doi:10.68041/jbpt.v2i3/01.